1

7th Meeting of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR)

17-20 October 2016, Raleigh, North Carolina, USA

The main objectives of the meeting are to:

1. Revise the WHO list of critically important antimicrobials for human medicine (WHO CIA list), and development of a WHO guideline based on the revised WHO CIA list;

2. Finalize the new edition of WHO-AGISAR guidance on integrated surveillance of antimicrobial resistance; and

3. Develop a global integrated surveillance protocol for ESBL-producing E.coli using a “One Health” approach.

Disclaimer:

In order to enhance its management of Conflicts of Interest as well as strengthen public trust and transparency

in connection with WHO meetings involving the provision of technical/normative advice, the names and brief

biographies of individuals (“Published Information” ) being considered for participation in such meetings are

disclosed for public notice and comment.

The Published Information is provided by the experts themselves and is the sole responsibility of the individuals

concerned. WHO is not responsible for the accuracy, veracity and completeness of the Published Information

provided. Furthermore, in no event will WHO be responsible or liable for damages in relation to the use of, and

reliance upon, the Published Information.

The comments received by WHO through the public notice and comment process are treated confidentially

and their receipt will be acknowledged through a generic email notification to the sender. Comments and

perceptions brought to the knowledge of WHO through this process are an integral component of WHO’s

conflict of interest assessment policy and are carefully reviewed. WHO reserves the right to discuss information

received through this process with the relevant expert with no attribution to the provider of such information.

Upon review and assessment of the information received through this process, WHO, in its sole discretion, may

take appropriate management action in accordance with its policies.

The participation of an expert in a WHO meeting does not imply that they are endorsed or recommended by

the World Health Organization nor does it create a binding relationship between the expert and WHO.

The list of participating experts, a summary of relevant interests disclosed by such experts, and any appropriate

mitigation measures taken by WHO relating to the management of conflicts of interests, will be reported

publically in accordance with WHO practice.

If you have any comments regarding the experts noted below, please send them to:

foodsafety@who.int by 15 October.

2

Biographies of participants for the 7th AGISAR Meeting

Professor Jacques Acar Professor, Clinical Microbiology and Infectious Diseases Emeritus Universite Pierre et Marie Curie, Paris, France Senior expert at the World Organisation for Animal Health (OIE) Paris, France Dr Jacques Acar, trained at the Pasteur Institute( Prof. Y. Chabbert) and at Harvard Medical School ( Prof. M. Finland), have been since 1972 chief of the research unit on antimicrobial resistance at the Ecole de Medecine " Broussais -Hotel- Dieu" Universite Pierre et Marie Curie, Paris. He is Founder member and former President of the ISID (International Society of Infectious diseases) and the ESCMID (European Society of Clinical Microbiology and Infectious Diseases). He established in the seventies with Pr Thomas O'Brien at Harvard University, one of the earliest system of antimicrobial resistance surveillance in hospitals. In 1981 at the foundation by Stuart B. Levy of APUA (Alliance for the Prudent Use of Antibiotics), he became member of the scientific advisory board. In the eighties he contributed to meetings held in Europe on antimicrobial resistance: Sweden, Denmark, France, UK, Germany, Czech Republic and Austria. Under the auspices of ESCMID, different study groups were launched to study antibiotics and bacterial resistance. He started ESGAR (European Study Group for Antibiotic Resistance) with Prof. F. Baquero and Prof. G. Cornaglia. He co-chaired the WHO meeting held in November 1994 in Geneva, which was followed by several publications and meetings (Berlin, Geneva, Oslo, Canberra) then by the establishment of WHO-AGISAR led by Dr. Awa Aidara-Kane. As Fellow of the American Academy of Microbiology, Dr J. Acar co-chaired the colloquium "Antibiotic Resistance, an ecological perspective on an old problem" October 12- 14 2008. Since 1999 Prof. J. Acar was with the ad hoc Committee at the OIE (World Organization for Animal Health) in charge to write and update the chapters of the" Terrestrial Animal Code" related to antibiotic usage and responsible use, surveillance of antimicrobial resistance and of antibiotic consumption, and critically important antibiotics for animals.

Professor Antoine Andremont Professor of Microbiology, University of Paris 7 Medical School Head laboratory of bacteriology, Bichat Hospital Paris, France MD 1976, Medical School of Tours University (Fr.). Ph. D. 1986, Pharmaceutical school of University Paris 11 ( Fr.). Board certified in

paediatrics, tropical medicine and microbiology. Training in epidemiology at the CDC (Atlanta, GA)1979. Research fellow at SUNY

(Brooklyn, NY) 1975. 1979-1996 clinical microbiologist at Institut Gustave Roussy (Fr.). 1988 -1996.Pr Microbiology at Pharmacy

School of University Paris 11. 1996-today Pr.microbiology, University of Paris7 Medical School, Head bacteriology Laboratory Bichat

hospital. 2005-Today, Expert -witness at the National Highest Court of Law. 2001-2011.member of the French Scientific Council for

Defense. AGISAR Member since 2009. SAB member GPI-AMR since 2010. Research focuses on the role of commensal microbiota in

bacterial resistance and infection. 214 pubmed publications (April 15th, 2014) .Google Scholar h indice 51. 20 patents connected

with academic research. Advisor of a biotech company (Davolterra) ( under the hospices of the French Law for Innovation and

Research).

Dr Sarah Cahill Food Safety Officer, FAO JEMRA secretariat, FAO office of Food Safety Rome, Italy As the FAO JEMRA Secretariat, Sarah is responsible for overseeing the provision of scientific advice on microbiological hazards in a wide range of foods, from fresh produce to meat and fish and an active participant in the Codex standard setting processes, facilitating the consideration of scientific advice in international standard setting. Her work also focuses on increasing the accessibility of risk assessment and scientific advice to the FAO and Codex Membership through the development of tools and approaches to support evidence-based decision-making in the wider management of food safety issues. She also supports capacity development activities in member countries, on implementation of Codex standards, food safety management and antimicrobial resistance. She is currently bringing her experience in microbiological food safety issues to the FAO work on antimicrobial resistance in the food and agriculture sector and has been involved in the development of FAOs action plan and is currently supporting its implementation.

Professor Paula Fedorka-Cray Professor and Head, Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University North Carolina, USA Dr Fedorka-Cray joined the USDA-ARS in 1991 studying the pathogenesis of Salmonella in swine, expanding into antimicrobial resistance in 1995. In 1999, she became Research Leader of the Bacterial Epidemiology and Antimicrobial Resistance Research Unit in Athens, GA studying the ecology, pathogenesis, and antimicrobial resistance of food borne pathogens. She also led the USDA animal arm of the National Antimicrobial Resistance Monitoring System from its inception in 1996-2012 and the USDA VetNet from 2004-2012. She holds a BS from the Pennsylvania State University, a MS from North Dakota State University (Bacteriology), a MAS degree from The Johns Hopkins University (Administration) and a PhD from the University of Nebraska Medical School (Veterinary Medical Sciences Interdisciplinary Area – Microbiology/Immunology). In 2014, she moved to Raleigh, NC as Head of the Population Health and Pathobiology Department at the College of Veterinary Medicine, North Carolina State University, where the mission of the Department is to recruit, train, inspire, and graduate Doctors of Veterinary Medicine of exemplary knowledge, skill, and character. She continues her research in antimicrobial resistance of food borne pathogens.

Dr Pilar Donado-Godoy PhD Researcher, Coordinator of the Unit of Food Safety, Centre of Biotechnology and Bioindustry, Corporacion Colombiana de Investigacion Agropecuaria (Corpoica)

3

Bogota, Colombia Dr Pilar Donado is a Veterinarian from the National University of Colombia. She holds a Master of Science in Veterinary Epidemiology

from the University of Guelph, Ontario Veterinary College, Canada and a PhD in Epidemiology from the University of California,

Davis. At present, she is working with the Colombian Corporation of Agricultural Research (Corpoica) as a Senior Researcher

coordinating the Unit of Food Safety and Quality for the Center of Biotechnology and Bioindustry in Bogotá. Dr Donado is leading the

development of the Colombian Integrated Program for Antimicrobial Resistance Surveillance (COIPARS), the first initiative of this

type in Latin America and which is being replicated in other countries of the continent.

Dr Sittana Shamseldin Elshafie Consultant Microbiology and Infection Control, Aspetar: Qatar Orthopedic and Sports Medicine Hospital Doha, Qatar Sittana Elshafie is a graduate from the College of Medicine University of Khartoum, Sudan, had MSc Microbiology from the London School of Hygiene and Tropical Medicine, Fellowship of The Royal College of Pathologists, UK, and a Post Graduate Diploma in Infection Control from The London School of Hygiene and Tropical Medicine. Dr Elshafie worked as Consultant Microbiologist and Ass. Prof of Microbiology in the University of Gezira, Sudan, Sultan Qaboos University in Sultanate of Oman, and Weill Cornel Medical College -Qatar. At Hamad Medical Corporation- Qatar, she served as Head of Microbiology and later Laboratory Director at Aspetar. Under her leadership Aspetar Lab acquired accreditation by the College of American Pathologists. She established the Infection Control for HMC and Aspetar and Chair the Institution Review Board of Anti-Doping lab-Qatar. Dr Elshafie main areas of interest are antimicrobial agents, antimicrobial resistance, the microbiome, and infection control.

Dr Marcelo Galas Specialist on Antimicrobial Resistance Surveillance HIV, Hepatitis, Tuberculosis, and Sexually Transmitted Infections and AMR unit Communicable Diseases and Health Analysis Department Pan American Health Organization/World Health Organization Washington DC, USA Dr. Galas is Specialist on Antimicrobial Resistance Surveillance within the Communicable Diseases and Health Analysis Department at the Pan American Health Organization/World Health Organization. He previously was Chief of Bacteriology Department at the National Institute of Infectious Diseases in Argentina, and General Coordinator of the Bacteriology Laboratory Networks System. This system includes the following national thematic surveillance networks: Bacterial Meningitis and Respiratory Tract Infections, Diarrhoea and Food Transmitted Infections, Sexually Transmitted Infections, Brucella Infections, Tuberculosis Infections and the WHONET-Argentina network for Antimicrobial Resistance Surveillance. He also was the manager of the last thematic network. At the Malbrán Institute, Dr. Galas has specialized in antimicrobial resistance, especially in clinical diagnosis, characterization of mechanisms of action and resistance, and surveillance. One of his greatest contributions was improving the quality of clinical diagnostic services in Argentina, including establishment of a national program of external quality assessment. Quality indicators over the past 15 years have demonstrated a significant decrease in diagnostic errors. Dr. Galas has collaborated with the Pan American Health Organization to introduce this successful model to nearly all Institutes of Health in Latin America. Dr. Galas was responsible for the coordination and integration of all bacteriological networks of the National Institute of Infectious Diseases orientated to the improvement of clinical diagnosis in health centers, introduction of molecular diagnostic methodologies, characterization of human pathogens and the detection and characterization of both hospital and community outbreaks . The introduction of new diagnostic methods with extensive training of laboratory professionals has improved the accuracy of diagnostic laboratories across Argentina. Dr. Galas has been Advisor of CLSI representing Latin American Countries for PAHO, Member of Accreditation Board of Argentinean Organization for Accreditation of Assay Laboratories and South American Coordinator of Global Foodborne Infectious Network (GFN) for WHO. Areas of expertise include clinical and molecular aspects of infectious diseases and

antimicrobial resistance, building capacity for bacteriological diagnostic, surveillance and quality assurance management.needs to get the new bio as he changed the job

Professor Kari Grave Professor, Department of Food Safety and Infection Biology, Faculty of Veterinary Medicine and Biosciences, Norwegian Institute of Life Science Scientific adviser (part time), Department of Health Surveillance, Norwegian Veterinary Institute Oslo, Norway Dr Kari Grave holds a MSc in Pharmacy from the University of Oslo. She obtained her PhD degree in veterinary pharmacoepidemiology from the Norwegian School of Veterinary Science in Oslo in 1991 and became a professor at Institute of Food safety and Infection Biology at the Norwegian School of Veterinary Science (now Norwegian Institute of Life Science) in 1999. She is engaged as scientific adviser at the Norwegian Veterinary Institute (since 1999) where she is responsible for surveillance of the consumption of antimicrobials in animals for the annual NORM-VET report. Since 2009 she has been engaged as national expert on secondment (50%) by the European Medicines Agency where she coordinates the European Surveillance of Veterinary Antimicrobial Consumption (ESVAC) project. Professor Dick Heederik Professor of Health Risk Analysis and Head of the Division of Environmental Epidemiology at the Institute for Risk Assessment Sciences, Utrecht University Utrecht, Netherlands Research has focused in recent years on antimicrobial resistance and respiratory disease and allergies resulting from human animal contact. In the first line of research, studies focused on the epidemiology of antimicrobial resistance among farmers, family members and veterinarians and transmission from animals to humans. Transmission was studied using observational epidemiological study designs in combination with molecular techniques to assess the presence of resistance genes. These studies were embedded in intervention studies in livestock production and were combined with risk assessment modelling studies for instance for MRSA and

4

ESBL producing micro-organisms. The work on respiratory diseases and allergies focused on the role of exposure to micro-organisms in the development of immune and allergic responses. Dick Heederik is chair of the expert panel of the Netherlands Veterinary Medicine Authority which is responsible for monitoring

antimicrobial use and benchmarking of livestock farms and veterinarians. Dr Rebecca Irwin Director, Surveillance Division, Canadian Integrated Program for Antimicrobial Resistance Surveillance, Laboratory for Foodborne Zoonoses, Public Health Agency of Canada Ontario, Canada Dr Irwin received her Doctor of Veterinary Medicine degree in 1986, and a Master of Science degree in Epidemiology in 1988 from

the Ontario Veterinary College, University of Guelph. Dr. Irwin has a long career with the federal government in Canada in both

agriculture and health departments. Since 1998 Dr Irwin has worked intensively on the antimicrobial resistance issue and was

instrumental in the founding and development of the Canadian Integrated Program for Antimicrobial Resistance Surveillance

(CIPARS). Dr Irwin is now Director of the Surveillance Division which operates the agri-food components of CIPARS at the

Laboratory for Foodborne Zoonoses, Public Health Agency of Canada. This programme encompasses surveillance of AMR and AMU,

research and risk assessment activities primarily focused on the animal, food and environmental aspects of the antimicrobial

resistance issue.

Dr Mohammad Aminul Islam Associate Scientist, Centre for Food and Water Borne Diseases, International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b) Dhaka, Bangladesh Dr Mohammad Aminul Islam is an Associate Scientist of the Centre for Food and Water Borne Diseases at the International Centre for

Diarrhoeal Disease Research, Bangladesh (icddr,b). Dr. Islam obtained his Ph.D. in Food Microbiology from Wageningen University,

the Netherlands and M.Sc. and B.Sc. (Hons) in Microbiology from the University of Dhaka, Bangladesh. He joined icddr,b in 2002 after

completing his M.Sc. Currently, he is leading the Food Safety Research Group and Food Microbiology Laboratory at icddr,b. He is a

GHES Fellow of the Fogarty International Centre, NIH, USA. Dr. Islam received advanced training from Institut Pasteur in France,

National Autonomous University of Mexico, Stanford University and University of California, Berkeley in USA and other reputed

organizations. He has been actively involved in strengthening national food safety systems and serving as an expert member of

committees dealing with food safety in Bangladesh. He is serving as a consultant for FAO in developing capacity of National Food

Safety Laboratory in Bangladesh and also serving as a consultant for WHO in developing food safety needs assessment tool. He is one

of the initiators of Biosafety and Biosecurity program in Bangladesh. His main research interests lie in the field of food safety with a

focus on microbiological contamination of food. The major areas of his research are: source tracking and transmission pathways of

foodborne bacterial pathogens, characterization of bacterial pathogens, emerging antibiotic resistance and transmission of multi-

drug resistant organisms in humans via food and food-producing animals. Dr. Islam has published a considerable number of original

papers in reputed journals and book chapters mainly in the areas of food microbiology and antimicrobial resistance.

Professor Lothar Kreienbrock Professor for Biometry, Epidemiology and Information Processing, University for Veterinary Medicine,

Hannover, Federal Republic of Germany Pr Lothar Kreienbrock is the Director of the Department of Biometry, Epidemiology and Information Processing at the University of

Veterinary Medicine in Hannover. By education he is a statistician and epidemiologist. His methodical expertise is in risk modelling

and techniques in monitoring and surveillance in the field of veterinary medicine and veterinary public health. In recent years Pr

Kreienbrock was heading a series of epidemiological studies in the area of zoonoses research with a special emphasis on antibiotics

use and antibiotics resistance. He is the principal investigator of VetCAb – Veterinary Consumption of Antibiotics (see vetcab-s.de) , a

sentinel-project, which summarizes the use of antibiotics in German livestock and of RESET (see http://reset-verbund.de/) a joint

consort project of human and veterinary medicine with a special emphasis on extended spectrum β-lactamases in enterobacteriacae.

Dr Simon Le Hello Co-director of the French National Reference Centre for E. coli, Shigella and Salmonella, Enteric Bacterial Pathogens

Unit and WHO-CC for reference and research on Salmonella, Institut Pasteur

Paris, FranceDr Simon Le Hello is a consultant microbiologist. He worked in Microbiology department of different Centers or

Hospitals in tropical areas, in particular at Institut Pasteur International network and affiliated (IP Guadeloupe, IP New Caledonia,

CIRMF-Gabon, French Guyana Hospital). He joined Institut Pasteur of Paris in 2008 where he is coordinating the French

microbiological surveillance of Shiga-toxin producing E. coli, Shigella and Salmonella with the help of national epidemiologists and

veterinaries. His main interest/expertise is genomic epidemiology of Salmonella population, in particular those resistant to

antibiotics and/or those involved in outbreaks. He is involved in international projects to study transmission of strains and plasmids

in relation to ESBL/carbapenemase producing bacteria worldwide.

Professor Ghassan Matar Professor , Department. of Experimental Pathology, Immunology & Microbiology, American University of Beirut Beirut, Lebanon

5

Professor Ghassan M. Matar is currently a Professor in the Department of Experimental Pathology, Immunology & Microbiology and

Laboratory Director of the Center for Infectious Diseases Research at the Faculty of Medicine, American University of Beirut (AUB).

Professor Matar was a post-doctoral fellow (Fulbright) at the Centers for Disease Control Prevention (CDC) and Department of

Microbiology and Immunology, Emory University in Atlanta, Georgia, USA. He was then appointed as Research Microbiologist at the

Division of Bacterial and Mycotic Diseases, CDC. Professor Matar was also appointed as Assistant Dean at the Faculty of Health

Science, AUB. He serves as resource advisor in the WHO-Advisory Group on Integrated Surveillance of Antimicrobial Agents

(AGISAR), and as American Society for Microbiology (ASM) Ambassador to Lebanon and member of the ASM Ambassador

Leadership Circle. Professor Matar’s Laboratory is also a PulseNet Laboratory certified by CDC/NAMRU3. To present he published 90

articles in refereed international journals and presented 115 abstracts in international, regional and local conferences. He received

funding from various extramural sources. Professor Matar’s research interests include: 1) Molecular mechanisms of resistance to

antimicrobial agents in pathogenic bacteria, namely methicillin resistance in S. aureus, macrolide resistance in S. pneumoniae and

carbapenem resistance in ESBL and non-ESBL producing Enterobacteriaceae, 2) Potential Treatment with antibacterial agents singly

or in combination of E. coli O157:H7 and E. coli O104:H4 infections in a mouse model, 3) Genetic basis of biofilm production in P.

aeruginosa isolated from patients with nosocomial infections and potential inhibition of biofilm formation by Micafungin in in vitro

and in vivo studies, 4) Expression levels of virulence factors produced by pathogenic bacterial agents in relation to disease

production, 5) Molecular epidemiology of foodborne diseases and nosocomial infections, 6) Assessment of combination therapy in

infections caused by carbapenem resistant Enterobacteriaceae harboring various carbapenemase encoding genes, 7) Molecular

characterization of Listeria monocyogenes from food items.

Dr Arno Muller Consultant, individual entity La Boissière, France Arno Muller is a consultant with expertise in antimicrobial use in humans and animals. In 2005, after he obtained his at University of

Besançon, France, he worked on the Danish DANMAP report until 2007. Between 2005 and 2011, he worked for the ESAC project at

University of Antwerp, Belgium. He was responsible for data management. Since 2011, as a consultant, he is providing support for

data management, reporting to the ESAC-Net surveillance network run by the European Centre for Disease Prevention and Control

(ECDC) and to the ESVAC project run by the European Medicines Agency (EMA).

Dr Raigamage Ranjith Damsiri Premathilaka Perera Head and Senior Lecturer, Department of Medical Microbiology, Faculty of Medicine, University of Kelaniya Ragama, Sri Lanka Dr Ranjith Perera is the Head of the Department of Medical Microbiology, Faculty of Medicine, University of Kelaniya, Sri Lanka. He

obtained his B.V.Sc degree from the University of Ceylon, his Diploma in Medical Microbiology from the Post Graduate Institute of

Medicine, University of Colombo, and his MPhil in Microbiology from the University of Colombo. He had worked as the Animal

Quarantine Officer, Sri Lanka, and was involved with public health aspects of imported and exported food of animal origin. Later, he

joined the Department of Medical Microbiology, Faculty of Medicine, University of Kelaniya, Sri Lanka, and was appointed as the

Head of the Department in 2007. His research interests include antimicrobial resistance and community acquired MRSA infections.

Dr Jorge Pinto Ferreira Junior consultant at SAFOSO Liebefeld, Switzerland Jorge received his Doctor of Veterinary Medicine degree from Universidade do Porto in 2001. The next five years, he practiced as a dairy cows’ clinician. Between 2005 and 2007 he completed his Masters studies about Food Science at Universidade Católica Portuguesa, and between 2007-2011 he completed his doctoral studies at North Carolina State University (about the transmission of MRSA between humans and animals). Jorge did an internship at WHO (Geneva, 2009). He joined SAFOSO in October 2012 being involved in the AMR EU – FP7 project EFFORT (http://www.effort-against-amr.eu/). Dr Thandavarayan Ramamurthy Scientist-F (Deputy Director Sr.Gd), Division of Bacteriology, National Institute of Cholera and Enteric Diseases Kolkata, India Dr. Ramamurthy's research activities have mainly focused on diarrheal disease surveillance, molecular diagnosis and epidemiology.

He is monitoring antimicrobial resistance (AMR) among hospital patients, at the community level and extensively working on the

molecular mechanism involved in AMR. He is the principal investigator of several international and national research projects on

diarrheal and food-borne infections. Dr. Ramamurthy has published more than 200 scientific papers in pear reviewed journals and

contributed several reviews and book chapters mainly on enteric pathogens. He is actively involved in WHO-GFN network and Pulse

Net Asia-Pacific. Dr. Ramamurthy holds M.Sc and Ph.D degrees from the Centre of Advanced Studies in Marine Biology, Porto-Novo,

Annamali University. He has worked as a post-doctoral fellow at the National Children’s Medical Research Center, Tokyo, Japan.

Mr Steven Roach Food Safety Program Director, Food Animal Concerns Trust Senior Analyst, Keep Antibiotics Working Chicago, USA Since 2001, Steven Roach has led the Food Safety Program of Food Animal Concerns Trust, an advocacy organization that promotes humane farming and the safe production of meat, milk, and eggs. His work at Food Animal Concerns Trust focuses on the human health impacts of animal agriculture including antimicrobial resistance. He is also a Senior Analyst for Keep Antibiotics Working, a

6

coalition of 14 health, consumer, and environmental advocacy organizations that have joined forces to combat the inappropriate use of antibiotics in food animals. He represents Consumers International at the Codex Committee on Residues of Veterinary Drugs in Food and was the Consumers International delegate at the Codex Ad hoc Task force on Antimicrobial Resistance. Steven Roach is also an active participant in the Antimicrobial Resistance Coalition, a group made up of civil society organizations and stakeholders from multiple sectors on six continents that was founded in May 2014 in anticipation of the 67th World Health Assembly discussions around antibiotic resistance. He helps develop and coordinate policy positions on antimicrobial resistance with dozens of advocacy organizations that are concerned about the impact of resistance on human health. He has an undergraduate degree in physics and philosophy and a M.A. in anthropology.

Professor Harvey Morgan Scott Professor, Department of Veterinary Pathobiology, Texas A&M University Texas, USA Dr H. Morgan Scott is a graduate veterinarian (DVM- Saskatchewan, Canada) holding a PhD in epidemiology (Guelph) and post-

doctoral training in public health (Alberta). In addition to private veterinary practice, he has worked in both government (food safety

surveillance) and academic settings. He is currently a tenured professor of epidemiology in the Department of Veterinary

Pathobiology at Texas A&M University. He was recently recruited as part of the Texas A&M University System Chancellor and the

University President initiatives on One Health and Infectious Diseases. He relocated from Kansas State University, where he held the

endowed E.J. Frick Professorship in Veterinary Medicine. In addition to WHO-AGISAR, he serves on a number of international and

national advisory committees concerning food safety, and leads several active U.S. federally funded multi-institutional research

grants. Much of his research emphasis has been on studying factors impacting antimicrobial resistance among commensal and

pathogenic enteric bacteria in food animal production systems, with a program spanning the realm from the molecular to the

sociological. In particular, he is interested in applying both epidemiological and ecological approaches to examine the emergence,

propagation, dissemination, and persistence of resistant enteric bacterial strains in integrated populations of animals, their food

products, and humans in a variety of settings. Using this knowledge, he hopes to identify opportunities to prevent and intervene

against resistance among enteric pathogens in animal agriculture; preferably, by developing readily adoptable and cost-effective

management practices suited to multiple production systems.

Dr Ellen Silbergeld Professor, Johns Hopkins University Bloomberg School of Public Health and Whiting School of Engineering, Departments of Environmental Health Engineering, Epidemiology, and Health Policy Maryland, USA Dr Silbergeld obtained her PhD in environmental engineering from Johns Hopkins University in 1972 and was a postdoctoral fellow at the Johns Hopkins schools of public health and medicine. Other professional appointments include a staff fellowship at NIH from 1975 to 1981, chief toxicologist for the Environmental Defense Fund (NGO) from 1981 to 1991; professor of toxicology and epidemiology at the University of Maryland Medical School from 1991 to 2001. S Since 2000, she has directed research on the impacts of antimicrobial use in agriculture on the emergence and dissemination of antimicrobial resistance in studies that have integrated epidemiological, ecological, and molecular approaches to understanding risks for farmers, workers, communities, and food consumers. These studies have involved international collaborations in Peru, Thailand, and the Netherlands. More recently, her group has modelled pathways and reservoirs for resistance within ecosystems and populations, using genomic and metagenomic methods. She has also collaborated on other projects at Hopkins on antimicrobial resistance, including a major community based intervention trial of mass administration protocols for preventing endemic diseases. She has served on many national and international committees including IARC (WHO, an expert committee of FAO-OIE-WHO on antimicrobial resistance in agriculture,) and US EPA. She has published over 300 papers and a recent book on industrial food animal production (Chickenizing Farms and Food, published by Johns Hopkins Press). Her research has been supported by US FDA, NIH, EPA, and NSF

Dr Ruby Singh Senior Regulatory Review Scientist, US Food and Drug Administration Maryland, USA Dr. Ruby Singh is a senior regulatory review scientist at the Center for Veterinary medicine, U.S. Food and Drug Administration (FDA). Dr. Singh interests are in the area of FDA’s regulatory policies that are aimed at assessing the relationships between antimicrobial uses in food animals and the potential human health consequences. Her current work focuses on the pre-approval review of complex qualitative and quantitative microbial food safety risk assessments for new antimicrobial animal drugs. In this regard, Dr. Singh works very closely with pharmaceutical companies in developing clinical studies to support the approval of new antimicrobial drug products, to ultimately develop risk management strategies to mitigate the public health risks from antimicrobial resistance as a result of these drug approvals. Dr. Singh is also a member of several working groups tasked with developing FDA’s policies on mitigating antimicrobial resistance risks to human health, including the development and implementation of strategies to improve stewardship of antimicrobial drug use in veterinary medicine. Dr. Singh is also involved with outreach to other government agencies, academia, the regulated industry, and the public, in promoting FDA policies on microbial food safety and other components of human food safety.

Professor Mark Sobsey Kenan Distinguished Professor of Environmental Sciences and Engineering, Department of Environmental Sciences and Engineering, Gillings School of Global Public Health, University of North Carolina Chapel Hill, North Carolina USA Dr. Mark Sobsey specializes in environmental health microbiology and water, sanitation and hygiene. His research, teaching and service encompass the detection, characterization, occurrence, environmental survival/transport/fate, treatment, human health effects characterization and risk assessment of viruses, bacteria and parasites of public health concern in water, wastewater, biosolids, soil, air and food for the prevention and control of water-, food- and excreta-borne disease. His research interests include

7

the occurrence of antimicrobially resistant bacteria in the environment, their transport and fate, their removal by wastewater and water treatment processes and their human health risks. He has served on advisory boards and groups and in other expert advisory capacities for the World Health Organization, The World Bank, US Environmental Protection Agency and US Centers for Disease Prevention and Control. He is a current member of the Science Advisory Board of the EU Joint Program Initiative on Antimicrobial Resistance (JPIAMR).

Dr John Stelling Co-Director of the WHO Collaborating Centre for Surveillance of Antimicrobial Resistance, based at the Brigham and Women’s Hospital Boston, USA Dr Stelling is Co-Director of the WHO Collaborating Centre for Surveillance of Antimicrobial Resistance, based at the Brigham and

Women's Hospital in Boston. Dr Stelling has worked since 1989 to support surveillance programmes for antimicrobial resistance in

over 110 countries, and is developer of the WHONET software used for the management, analysis and sharing of microbiology

laboratory data. Dr Stelling was a Medical Officer with the World Health Organization for three years in the Antimicrobial Resistance

Unit of the Department of Communicable Diseases Surveillance and Response. Dr Stelling has an MPH from the Johns Hopkins School

of Hygiene and Public Health and an MD from Harvard Medical School and completed an internship in family practice at San

Francisco General Hospital.

Dr Neelam Taneja Professor Medical Microbiology at Postgraduate Institute of Medical Education and Research Chandigarh, India Dr Taneja heads the Enteric Division at Deptt of Medical Microbiology at PGIMER, Chandigarh , a 2000 bed tertiary care premier referral Institute in India catering to seven states north of Delhi. She provides diagnostic(conventional as well as molecular), surveillance ,referral services and conducts research in the field of diarrhea , food borne infections and urinary tract infections with special focus on epidemiology and drug resistance . Antimicrobial resistance in Entero and uro pathogens is being constantly monitored at community and hospital level by both phenotypic and molecular assays .The lab is using various multiplex PCR assays to detect foodborne pathogens .Her lab plays an important role in investigating and managing outbreaks of cholera, and food poisoning in this geographic area. She holds an international patent for a putative Shigella vaccine in USA. Her current work includes study of antimicrobial resistance in nontyphoidal salmonella, Shigella , diarrhoeagenic E.coli and studying the human zoonotic interface in these organisms as well as developing newer antimicrobial agents through bio-informatics, immunology of Shigella in human hosts using an invitro culture system and colonization factor analysis of Enterotoxigenic E.coli across north India. In the WHO funded project, “Strengthening district public health laboratories for laboratory surveillance of communicable diseases of outbreak potential”, she developed 11 labs of Punjab, Haryana, Uttarakhand and trained with establishment of stool referral system for gastroenteritis. She has various international honors including many research awards, fellowships from WHO, Pasteur Institute, International Development award for young woman scientist conferred by International society of infectious Diseases and several international travel awards including five from NIH, and 121 highly peer-reviewed articles .She is a co-PI in WHO-AGISAR project on antimicrobial resistance of foodborne pathogens

Dr Olivier Vandenberg Professor, Microbiology in the Faculty of Medicine and the Public Health School of the Université Libre de Bruxelles Head, Department of Microbiology of iris-Lab, Iris- Brussels Public Hospitals Network Brussels, Belgium Olivier Vandenberg graduated as Medical Doctor at the Université Libre de Bruxelles, Brussels, Belgium in 1996. In 2001, he obtained a speciality training in clinical microbiology at the same university and presented a PhD thesis in Biomedical Sciences in 2006. In 2008, he was appointed Head of the Department of Microbiology of iris-Lab. In addition, he is currently Professor of Microbiology in the Public Health School and in the Faculty of Medicine of the Université Libre de Bruxelles. Most of his researches focus on emerging foodborne pathogens in both industrialized and developing countries. Since 2000, he has also supervised the consolidation of several microbiology laboratories allowing the implementation of infectious disease surveillance programmes in low and middle incomes countries. Besides this, he also collaborates with different manufacturers in the development of new approaches for the diagnosis and control of infectious diseases.

Professor Jaap Wagenaar Professor, Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands. Director, WHO Collaborating Center for Campylobacter and OIE Reference Laboratory for Campylobacteriosis Utrecht, The Netherlands Jaap Wagenaar is expert in the field of zoonoses, including food safety, and antimicrobial resistance. He was trained as veterinarian

in Utrecht and obtained his PhD at the same university. In 1996 he started his research group at the Central Veterinary Institute in

Lelystad, the Netherlands, on food safety and in particular on Campylobacter. Starting in 2000, Jaap Wagenaar became active as

steering committee member and trainer in the WHO-Global Foodborne Infections Network (WHO-GFN). From 2004-2006 he worked

with WHO (Headquarters, Geneva, Switzerland, and for the Tsunami-relief operations to WHO Indonesia), the Centers for Disease

Control and Prevention (Atlanta, US) and the USDA Western Regional Research Center (Albany, Ca, US). From 2006, he is appointed

as chair in Clinical Infectious Diseases at the Faculty of Veterinary Medicine, Utrecht University. His research group at the Vet School

is focussing on Campylobacter and antimicrobial resistance. He is currently coordinator of an EU-project on antimicrobial resistance

(EFFORT).

8

Dr Gun-Jo Woo Professor, Department of Biotechnology, Korea University Seoul, South Korea Dr Woo’s research area is study on prevalence and characterization of antimicrobial resistance (AMR) of isolates from foods and environment and comparison of AMR with clinical isolates. He got his Ph.D. in Dept. of Food Science and was Postdoctoral Research Associate in Dept. of Microbiology at University of Illinois at Urbana-Champaign, USA. He served as Chair for Joint FAO/WHO/OIE Expert Consultation on AMR in Aquaculture (2006) and for the 1st session of Ad Hoc Codex Intergovernmental Task Force on AMR (2007). He was director of National Antimicrobial Resistance Management Program (NARMP), director of Dept. of Food Microbiology and director of Center for Food Safety at Korea Food and Drug Administration (2001~2008). He joined as a full professor of Food Safety at Korea University in 2008 and has also worked as ADB International Consultant for Lao PDR National Food Safety project since 2013.

9

Biographies of participants for a Guideline Development Group discussions on 18-20 October 2016

Professor Peter Collignon Executive Director, ACT Pathology, Canberra Hospital, Garran, Australia Professor, Medical School, Australian National University Canberra, Australia Professor Collignon is currently Executive Director of ACT Pathology. He was previously director of the Infectious Diseases unit and Microbiology at Canberra Hospital and where he has worked since 1987. He continues to be involved in the care of patients as an Infectious Diseases Physician and also is involved with laboratory work as a clinical Microbiology. He is a Professor at the Medical School, Australian National University. His main research interests involve antibiotic resistance (both resistant bacteria acquired via the food chain and cross infections with resistant bacteria between people), Influenza, blood stream infections, Infection Control and Healthcare-associated infections (especially from IV catheters). He has had published over 200 research articles, review articles and book chapters in the peer reviewed scientific literature. He has been a member of many national and international committees, including those of the Australian Quality and Safety

Commission. He has been on many expert committees of the World Health Organization (WHO) on the issue of antibiotic resistance

and the use of antibiotics in food animals since 2000. He was made a Member of the Order of Australia (AM) in June 2009 for services

to Infectious diseases, Microbiology and Infection Control.

Professor John Conly Professor of Medicine, Departments of Medicine, Microbiology, Immunology & Infectious Diseases, Pathology & Laboratory Medicine, University of Calgary Medical Officer, Infection Prevention and Control, Calgary Zone, ALBERTA HEALTH SERVICES, Foothills Medical Centre Alberta, Canada John Conly is a Professor and former Head of the Department of Medicine at the University of Calgary and the Alberta Health Services - Calgary and Area, Canada, where he developed the largest Alternate Funding Plan for internal medicine in Canada and spearheaded the development of 17 new innovative clinics and initiatives including the use of alternate care providers, central access and triage to improve wait times and founding the Ward of the 21st Century. He is medically trained as a specialist in Infectious Diseases, and was a founding Co-Chair of the Canadian Hospital Epidemiology Committee, past President of the Canadian Infectious Disease Society, past Chairman of the Board for the Canadian Committee on Antibiotic Resistance and a previous Vice Chair for the Canadian Expert Drug Advisory Committee. He is currently the Medical Director of the W21C, a member of both the Institute for Public Health and the Synder Institute for Chronic Diseases at the University of Calgary, a Board member for the Canadian Foundation for Infectious Diseases, the Editor-in-Chief for the Canadian Journal of Infectious Diseases and Medical Microbiology and a consultant to the WHO for the GIPC Network and the WHO Advisory Group on Integrated Antimicrobial Surveillance. He has published over 300 papers, and has received numerous career honours in teaching, research, mentorship, innovation and service. His current interests focus on innovations in health care, patient safety and antimicrobial resistance.

Dr Fred Angulo Associate Director for Science, Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention Atlanta, USA Dr Angulo is the senior scientist in the Division of Global Health Protection which includes several broad-based infectious disease capacity building programs including the Global Health Security Agenda, the Global Disease Detection Program, and the Field Epidemiology Training Program. He obtained a DVM from the University of California – Davis and PhD in Epidemiology from the School of Public Health at the University of California Los Angeles. He is associate professor of epidemiology at Emory University Rollins School of Public Health. He joined CDC in 1993 and served 16 years in the foodborne diseases leading efforts such as FoodNet, NARMS, and WHO Global Foodborne Diseases Network. He also served as a Steering Member of WHO FERG for 8 years. For the past 7 years, he has served in the Center for Global Health on efforts to enhance countries efforts to more rapidly detect and respond to public health events of international importance.

Professor Antoine Andremont Professor of Microbiology, University of Paris 7 Medical School Head laboratory of bacteriology, Bichat Hospital Paris, France MD 1976, Medical School of Tours University (Fr.). Ph. D. 1986, Pharmaceutical school of University Paris 11 ( Fr.). Board certified in

paediatrics, tropical medicine and microbiology. Training in epidemiology at the CDC (Atlanta, GA)1979. Research fellow at SUNY

(Brooklyn, NY) 1975. 1979-1996 clinical microbiologist at Institut Gustave Roussy (Fr.). 1988 -1996.Pr Microbiology at Pharmacy

School of University Paris 11. 1996-today Pr.microbiology, University of Paris7 Medical School, Head bacteriology Laboratory Bichat

hospital. 2005-Today, Expert -witness at the National Highest Court of Law. 2001-2011.member of the French Scientific Council for

Defense. AGISAR Member since 2009. SAB member GPI-AMR since 2010. Research focuses on the role of commensal microbiota in

bacterial resistance and infection. 214 pubmed publications (April 15th, 2014) .Google Scholar h indice 51. 20 patents connected

with academic research. Advisor of a biotech company (Davolterra) ( under the hospices of the French Law for Innovation and

Research).

Dr Elisabeth Erlacher-Vindel Deputy Head of the Scientific and Technical Department , World Organisation for Animal Health (OIE) Paris, France

10

Dr Elisabeth Erlacher-Vindel graduated from the Veterinary University, Vienna, Austria. She was first employed and obtained her Doctor’s Degree in the Institute of Breeding and Genetics (Vienna, Austria) and later worked in Paris in the Institut Pasteur . After having worked as a field veterinarian in different countries, she worked in the French professional dairy organisation, where she became Head of the Food Safety and Environment Unit and Deputy Director of the Scientific Department. She joined the World Organisation for Animal Health (OIE) in 2008 as Deputy Head of the Scientific and Technical Department and is the Focal Point for tripartite activities on antimicrobial resistance.

Dr Cindy Friedman Epidemiology Team Lead, National Antimicrobial Resistance Monitoring System (NARMS), Enteric Diseases Epidemiology Branch, Centers for Disease Control and Prevention Atlanta, GA USA Dr. Friedman is the epidemiology team lead for the National Antimicrobial Resistance Monitoring System (NARMS) at The U.S. Centers for Disease Control and Prevention. Her work includes surveillance and epidemiologic studies of infections caused by antibiotic resistant foodborne and enteric bacteria. Dr. Friedman is board certified in Infectious Diseases. She completed her Infectious Disease post-doctoral fellowship training at Cornell University Medical College in New York where she worked on the molecular epidemiology and molecular methods of subtyping Mycobacterium tuberculosis. Dr. Friedman joined CDC as an Epidemic Intelligence Officer in the Enteric Diseases Branch in 1995, after which she spent several years working on outbreak investigations, surveillance, and epidemiologic research related to Helicobacter and Campylobacter infections. Dr. Friedman spent several years in Washington, D.C. at the Fogarty International Center and at CDC working on many infectious disease, epidemiological, and bioterrorism policy issues. She returned to Atlanta in 2006, where she worked as the Medical Director for Get Smart: Know when Antibiotics Work, a CDC program focused on the judicious use of antibiotics in the healthcare community. During her career, Dr. Friedman has authored many peer reviewed publications, book chapters, and has collaborated on international projects ranging from health surveillance in refugees in West Timor to integrated disease surveillance in Guatemala.

Dr Aidan Hollis Professor of Economics, University of Calgary Calgary, Canada Aidan Hollis is Professor in Economics at the University of Calgary, and Vice-President of Incentives for Global Health, a US-based NGO focused on the development of the Health Impact Fund proposal. Hollis studied at Cambridge University and the University of Toronto, where he obtained a PhD in economics. His research focuses on innovation and competition in pharmaceutical markets, and he has published over forty peer-reviewed articles and two books in a range of fields of economics. In 2003-4 he served as the T.D. MacDonald Chair in Industrial Economics at the Competition Bureau. He holds grant funding from the Canadian Institutes for Health Research (on innovation and orphan drugs) and the European Research Council (on measuring and rewarding health impact). Professor Samuel Kariuki Professor and Head of Department, Centre for Microbiology Research, Kenya Medical Research Institute (KEMRI) Nairobi, Kenya Sam Kariuki is a Chief Research Scientist and Head of Department, Centre for Microbiology Research at KEMRI in Nairobi and a

Wellcome Trust Sanger Institute International Fellow. He is also a visiting Professor of Tropical Microbiology, Nuffield Department of

Medicine, University of Oxford, UK. He obtained his PhD in Tropical Medicine from University of Liverpool, UK in 1997, and has a MSc

in Pharmacology and Toxicology and a basic degree in Veterinary Medicine. He has research interest in the epidemiology and

molecular characterisation of enteric bacterial pathogens and antimicrobial resistance epidemiology and surveillance, including for

invasive non-typhoidal salmonellosis (NTS) and typhoid fever, which are endemic in sub-Saharan Africa. Other areas of interest have

been in surveillance and monitoring antimicrobial resistance among other key foodborne pathogens in Kenya including Shigella spp,

Vibrio cholerae and Escherichia coli. He has authored/co-authored in over 120 papers in peer-reviewed journals and written

chapters in 3 text books in related fields of Antimicrobial resistance and Food safety.

Dr Hyo-Sun Kwak Director of Enteric Disease Division, Center for Infectious Disease, Korea National Institute of Health, Centers for Disease Control & Prevention Chungcheongbuk-do, Republic of Korea Dr. Hyo-Sun KWAK is the Director of Enteric Disease Division of Centers for Disease

Control and Prevention. She obtained her PhD degree in Microbiology from Sungshin Women’s University, Korea. She joined the

Ministry of Food & Drug Safety(MFDS, formerly Korea Food & Drug Administration) as a researcher in 1991. She visited the US

Centers for Disease Control & Prevention as a visiting scientist in 1995. She had a wealth of experience mainly in Microbiology

Division and Foodborne Disease Prevention & Management Division in MFDS, Korea. She had contributed to the CODEX Task Force

on Antimicrobial Resistance for organizing and operating as Korean Secretariate from 2007 to 2010. She is currently a director at

Korea CDC, working on foodborne and waterborne disease in human. She is researching about rapid detection method development,

antimicrobial resistance test and managing the national surveillance project. She has spent most of her career in national and global

food safety especially for the characterization of foodborne pathogens and antimicrobial resistant bacteria. Dr Mauricio Ferri Critical Care Medicine – Health Services Research Princeton, USA Dr Ferri is a Brazilian critical care physician and health services researcher interested in evidence-based medicine and guideline

development methods for public health emergencies. He participated in the World Health Organization (WHO) clinical management

team for the 2014-2016 Ebola Outbreak in West Africa and had multiple deployments to Sierra Leone. He was a member of the

guideline development group for the WHO Rapid Advice Guidelines for Personal Protective Equipment for Ebola in 2014 and was a

11

peer reviewer for the “WHO Handbook for Guideline Development 2 ed.” chapter on rapid advice guidelines. Since March 2016, he is

a full-time consultant for the WHO Guideline Review Committee secretariat (GRC) developing methods, processes and assessment

standards for ultra-fast guidelines (development time less than 3 weeks) in public health emergencies. As part of his consultancy

with the GRC secretariat, he reviews the development methods and processes of all types of WHO guidelines submitted for GRC

approval.

Professor Scott McEwen Professor, Department of Population Medicine, University of Guelph Ontario, Canada Dr Scott McEwen obtained his DVM and Doctor of Veterinary Science degrees from the University of Guelph. He is currently a

professor in the Department of Population Medicine, Ontario Veterinary College. His research on antimicrobial resistant bacteria and

other foodborne pathogens focuses on the distribution of fecal shedding in animals and risk factors for infection in animals and

humans. He also studies surveillance of antimicrobial use and assessment of human health risks from antimicrobial use in animals.

Dr Gérard Moulin Deputy Director, National Agency for Veterinary Medicinal Products (ANMV/Anses) Fougères, France Gérard Moulin is Deputy Director of the National Agency for Veterinary Medicinal Products (Fougères, France) since May 2008. Before his appointment, he was head of Marketing Authorisation Department and in charge of International Affairs. His main areas of activities are antimicrobial resistance, pharmacokinetics and residues of antimicrobials, Veterinary pharmaceutical legislation, Benefit risk analysis. At the National level, he is responsible of the French survey of veterinary antimicrobial sales and is part of different working groups

on antimicrobial resistance. At the European Level, he was Chairman of the Committee of Veterinary medicinal products between

2003 and 2010. He is currently the French representative of the ESVAC network (European Surveillance of Veterinary Antimicrobial

Consumption) and participates to a number of EU Working parties on antimicrobial resistance. He is currently the Chair of the AMEG

(Antimicrobial Expert Group) and of the JIACRA (Joint Inter-Agencies Consumption and Resistance Analysis EU expert Group). At the

international level, he participated to tripartite WHO/OIE/FAO consultations on antimicrobial resistance and is an expert working

on a regular basis for OIE. He was involved as an expert in different WHO activities and is a Member of WHO-AGISAR since 2009.

Dr Antoinette Ngandjio Head, Laboratory of Hygiene and Environment (Food and Water Microbiology) Centre Pasteur of Cameroon Yaoundé, Cameroon Dr Antoinette Ngandjio obtained a MD in “Hydrobiology and Parasitology” (University of Yaounde I, Cameroon)), in “Tropical

Infectious Disease” (EDR – AUF, Gabon) and in “Public Health and Developing Countries” (University of Paris VI - Pierre et Marie

Curie, France). She obtained her PhD in Microbiology from University of Paris VI and joined Centre Pasteur of Cameroon in 2003 as

Assistant Researcher in the laboratory of Bacteriology. Then, she became in 2006, responsible for research activities in the

Laboratory of Experimental Bacteriology. Her main area of Research is Antimicrobial Resistance of enteric and zoonotic bacteria

from human and animal origins. She is actively involved in WHO – Global Foodborne Network (GFN) activities and co-organizes

workshops held in Cameroon. Since 2013, she is the head of Laboratory of Hygiene and Environment, which is accredited according

to ISO 17025 Standards in Food and Water Microbiology.

Dr Henk Jan Ormel Senior Veterinary Policy Advisor of the Chief Veterinary Officer of the Food and Agriculture Organization of the United Nations (FAO), coordinator of FAO’s AMR Working group, Technical Focal Point on AMR Tripartite issues, coordinator of Global Health Security Agenda issues Rome, Italy Henk Jan Ormel graduated from The Faculty of Veterinary Medicine of the State University of Utrecht in 1983. He became co-owner of a mixed practice in the southern part of the Netherlands and practised as a general practitioner in large, companion and zoo animals. In 1992 he moved to the eastern part of the Netherlands and became co-owner of a private practice. From 1995 -2002 he was, besides his work as a veterinary practitioner, a Board Member of AUV, a Dutch Veterinary Medicines Corporation and from 1999-2002 he was Chairman of the Board. In 2002 Henk Jan Ormel ran and was elected to the Dutch Parliament out of anger against the non-vaccination policy of the EU during the outbreaks of foot-and-mouth disease of the time. . In parliament he was spokesman for his political party (CDA: Christian Democratic Party) on animal health and animal welfare but also on human medical-ethical issues, biotechnology, European and Foreign affairs. From 2007 through 2010 he was the Chairman of the Foreign Affairs Committee of the Second Chamber of the Dutch parliament (States General). From 2008 to 2010 he was also Vice President of NATO Parliamentary Assembly and from 2011 he is Vice Chairman of AWEPA (Africa with European Parliamentarians). Upon resigning from Parliament in September 2012, Her Majesty the Queen bestowed upon him the Knight in the Order of Oranje Nassau. October 2012 he was seconded by the Dutch Ministry of Economic Affairs to FAO, where he presently serves in the animal health service of the agricultural department (AGAH) as Senior Policy Advisor to the Chief Veterinary Officer and co-coordinator of FAO’s working group on Anti-Microbial Resistance (together with Dr Alessandro Patriarchi). Dr Bernard Rollin University Distinguished Professor of Philosophy, Biomedical Sciences, Animal Sciences; University Bioethicist Colorado State University

12

Rollin's scholarly interests include both traditional philosophy and applied philosophy, and he specializes in animal ethics, animal pain and animal consciousness. He is the author of 20 books and over 500 articles, and has done over 1500 invited lectures in 28 countries. He was a principal architect of 1985 US federal law protecting laboratory animals. Rollin is a weightlifter and motorcyclist. He was recently awarded the Lifetime Achievement Award by Public Responsibility in Medicine and Research (PRIM&R)

Dr Flavia Rossi Director, Microbiology Laboratory , Hospital das Clínicas, Pathology Department, Faculty of Medicine of the University of São Paulo ( FMUSP) Sao Paulo, Brazil Dr Rossi is the Pathologist Director for the Central Microbiology Laboratory from the 10 hospitals that belong to the University Complex at the University of São Paulo, Brazil since 1999. From 1996 t0 2002 she was the General Pathologist Director of the Institute of Infectology Emilio Ribas, SãoPaulo. 1997-2006: Ambassador for Brazil. Member of the International ASM ( American Society of Microbiology) Committee. 2008-2013: CLSI ( Clinical and Laboratoy Standard Institute) Advisory member for Latin America. 2008_ until today: PAHO_TAG ( Technical Antimicrobial Group) board member. Her area of research is phenotypic and genotypic characterization of human pathogens and antimicrobial resistance surveillance.

Dr David Wallinga Senior Health Officer, Natural Resources Defense Council San Francisco, USA Dr. Wallinga is a physician-advocate working for the last 16 years at the intersection of food, agriculture, and public health policy. At NRDC, one of the largest U.S. consumer and environmental groups, his primary focus is to address the overuse of medically important antimicrobials in livestock and poultry production, through education, research and advocacy. Since 2000, he has been a co-founder and steering committee member of Keep Antibiotics Working: The Campaign to End Antibiotic Overuse. He has also been a representative to the international Antibiotic Resistance Coalition. Dr. Wallinga’s previous jobs were as founder of Healthy Food Action, and founder of the Health program at the Institute for Agriculture and Trade Policy. From 2009-2010, he was a Wm. T Grant Foundation Distinguished Fellow in Food Systems and Public Health at the University of Minnesota, from which he also obtained his medical degree. Dr. Wallinga also holds a bachelor¹s degree from Dartmouth College and a master¹s degree in public affairs from Princeton University. He is based in San Francisco and Minnesota.

Dr Hatie E. Webb Postdoctoral Research Associate at Texas Tech University, Lubbock, Texas and the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) Maisons-Alfort, France Hattie E. Webb obtained her PhD in Animal and Food Science from Texas Tech University. Her dissertation focused on antimicrobial resistance in Gram-negative bacteria along the agri-food production chain, with special focus on resistance to colistin and carbapenems, and harbourage of Salmonella in bovine lymph nodes. Currently, she is working on a collaborative research effort between Texas Tech and ANSES to better characterize colistin resistance.